In 2014, the EMCDDA took the decision to carry out a limited follow-up study of the EMCDDA Paper Drug squads: units specialised in drug law enforcement in Europe (EMCDDA, 2013), with the aim of monitoring possible changes and trends in drug supply reduction resulting from law enforcement...

The problem drug use (PDU) indicator is one of the five EMCDDA key epidemiological indicators, addressing key aspects of the prevalence and harms of drug use at the European level. National experts from the PDU network provide prevalence estimates of high-risk drug use by substance and the...

Comparable and reliable data about the number and characteristics of people entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatment entrants through the Treatment demand indicator...

Injecting drugs is a key risk factor for contracting viral and other infections. Blood-borne infections acquired through the sharing of injecting equipment are among the most serious health harms of drug use. The drug-related infectious disease (DRID) indicator collects data on the extent of...

This report is prepared in the framework of the EMCDDAIPA5 project 'Further preparation of the IPA beneficiaries for their participation with the European Monitoring Centre for Drugs and Drug Addiction' funded by the European Commission. It provides the top-level overview of the drug phenomenon...